Article metrics

Download PDFPDF

654 A phase I/II trial investigating safety and efficacy of autologous TAC01-HER2 in relapsed or refractory solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2023 to November 2024

AbstractFullPdf
Nov 2023345021
Dec 20234405
Jan 20246907
Feb 20245602
Mar 20246004
Apr 202410800
May 20244102
Jun 20245705
Jul 20248707
Aug 20244801
Sep 20245304
Oct 20245603
Nov 202411102
Total1135063